← Back to signals
NTRA
LONGINSIDER SELLNATERA INC
Funds
3
Score
3.50
vs SPY
-4.6%
Stock return (since Q-end)
+11.7%
SPY return (since Q-end)
+16.3%
Current price
$223.37
News Summary
PositiveNatera delivered a strong Q1 2026 with 38.8% YoY revenue growth ($696.6M vs. $613.9M consensus), 54.4% oncology test growth, and raised full-year 2026 guidance by $120M at midpoint to $2.74–$2.82B. Key catalysts include FDA approval of Signatera CDx as first blood-based MRD companion diagnostic, commercial launch of Zenith Genomics for rare disease diagnosis, and Japan market expansion opportunity for colorectal cancer screening.
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | QoQ | Status |
|---|---|---|---|---|---|---|
| Maverick Capital | Lee Ainslie | 1.2M | +228K | $234.3B | +24% | Existing |
| Point72 | Steve Cohen | 444K | +444K | $88.8B | — | NEW |
| Duquesne Family Office | Stanley Druckenmiller | 3.1M | +552K | $613M | +22% | Existing |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed |
|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 2K | $202.84 | $0.34M | 2026-05-26 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 1K | $202.84 | $0.29M | 2026-05-26 |
| Sheena Jonathan | — | SELL | 285 | $202.68 | $0.06M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 9 | $203.29 | $0.00M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 345 | $201.11 | $0.07M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 290 | $202.58 | $0.06M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 30 | $202.84 | $0.01M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 96 | $199.43 | $0.02M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 360 | $201.19 | $0.07M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 85 | $199.52 | $0.02M | 2026-05-13 |
| Sheena Jonathan | — | SELL | 200 | $205.43 | $0.04M | 2026-05-08 |
| Sheena Jonathan | — | SELL | 900 | $207.24 | $0.19M | 2026-05-08 |
| Sheena Jonathan | — | SELL | 700 | $208.13 | $0.15M | 2026-05-08 |
| Sheena Jonathan | — | SELL | 200 | $209.57 | $0.04M | 2026-05-08 |
| Sheena Jonathan | — | SELL | 1K | $210.34 | $0.24M | 2026-05-08 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 2K | $206.77 | $0.35M | 2026-05-05 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 1K | $241.39 | $0.35M | 2026-05-05 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 948 | $205.22 | $0.19M | 2026-05-05 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 3K | $206.77 | $0.60M | 2026-05-05 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 482 | $210.49 | $0.10M | 2026-05-04 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN | SELL | 722 | $206.16 | $0.15M | 2026-05-04 |
| Sheena Jonathan | — | SELL | 107 | $206.16 | $0.02M | 2026-05-01 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 313 | $206.16 | $0.06M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 405 | $206.16 | $0.08M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 560 | $200.95 | $0.11M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 520 | $201.60 | $0.10M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 505 | $203.32 | $0.10M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 865 | $204.47 | $0.18M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 400 | $205.31 | $0.08M | 2026-05-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 150 | $206.93 | $0.03M | 2026-05-01 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 291 | $206.16 | $0.06M | 2026-05-01 |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 902 | $206.16 | $0.19M | 2026-05-01 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 330 | $206.16 | $0.07M | 2026-05-01 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 500 | $192.13 | $0.10M | 2026-04-29 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 1K | $193.78 | $0.19M | 2026-04-29 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 1K | $194.82 | $0.21M | 2026-04-29 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 200 | $197.26 | $0.04M | 2026-04-29 |
| Sheena Jonathan | — | SELL | 805 | $196.99 | $0.16M | 2026-04-29 |
| Sheena Jonathan | — | SELL | 2K | $196.22 | $0.44M | 2026-04-29 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 300 | $190.12 | $0.06M | 2026-04-29 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $204.39 | $0.24M | 2026-04-27 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 873 | $203.75 | $0.18M | 2026-04-27 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 988 | $204.39 | $0.20M | 2026-04-27 |
| Sheena Jonathan | — | SELL | 285 | $203.75 | $0.06M | 2026-04-27 |
| Sheena Jonathan | — | SELL | 188 | $204.39 | $0.04M | 2026-04-27 |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 4K | $204.39 | $0.73M | 2026-04-27 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 771 | $203.75 | $0.16M | 2026-04-27 |
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | SELL | 1K | $204.39 | $0.25M | 2026-04-27 |
| Chapman Steven Leonard | CEO AND PRESIDENT | SELL | 2K | $203.75 | $0.46M | 2026-04-27 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 771 | $203.75 | $0.16M | 2026-04-27 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER | SELL | 917 | $204.39 | $0.19M | 2026-04-27 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 997 | $203.75 | $0.20M | 2026-04-27 |
| Sheena Jonathan | — | SELL | 750 | $199.59 | $0.15M | 2026-04-17 |
| Sheena Jonathan | — | SELL | 750 | $199.66 | $0.15M | 2026-04-17 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $201.32 | $0.21M | 2026-04-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 952 | $203.31 | $0.19M | 2026-04-01 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 300 | $200.79 | $0.06M | 2026-04-01 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 2K | $202.01 | $0.36M | 2026-04-01 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 3K | $203.07 | $0.65M | 2026-04-01 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 1K | $203.83 | $0.24M | 2026-04-01 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | SELL | 2K | $205.00 | $0.39M | 2026-04-01 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | SELL | 1K | $202.36 | $0.20M | 2026-04-01 |